1-3 of 3
Michael O'Dwyer, MD, FRCPath
Close
Sort by
Journal Articles

G2/M Arrest Sensitizes Chronic Myelogenous Leukemia Cells to TRAIL-Induced Apoptosis

David Devlin, Medical, Student, Eva Szegezdi, Post-Doctoral, Researcher, Paavilainen Tanja, Student, Orsolya Orosz, Student, Michael O'Dwyer, MD, FRCPath, Michael Carty, Senior, Lecturer, Afshin Samali, PhD, SeĢverine Cruet Hennequart, PhD
Journal: Blood
Blood (2010) 116 (21): 4465.
https://doi.org/10.1182/blood.V116.21.4465.4465
Published: 2010
Journal Articles

Nilotinib 300 Mg Twice Daily as First Line Treatment of Ph-Positive Chronic Myeloid Leukemia In Chronic Phase: Updated Results of the ICORG 0802 Phase 2 Study with Analysis of the GeneXpert System Versus IS BCR-ABL RQ PCR.

Eibhlin Conneally, MB, MRCPI, FRCPath, PhD, Ronan T Swords, MD, MRCPI, FRCPath, Francis J. Giles, MB, MD, FRCPI, FRCPath, Mary Frances McMullin, MD, Philipp le Coutre, Stephen Langabeer, Marzena Wieczorkowska, Cliona McDowell, Brian Moulton, Karine Egan, Michael O'Dwyer, MD, FRCPath
Journal: Blood
Blood (2010) 116 (21): 3427.
https://doi.org/10.1182/blood.V116.21.3427.3427
Published: 2010
Journal Articles

The BH3 Mimetic, ABT-737, Overcomes Stromal-Mediated Pro-Survival Signals and Synergizes with PHA-767491, a Dual Cdc7/CDK9 Inhibitor, In Acute Myeloid Leukaemia

Ruth C Morrell, MBBCh, FRCPath, Eva Szegezdi, PhD, Anna Halpin-McCormick, BSc, Karen Cawley, BSc, Afshin Samali, PhD, Michael O'Dwyer, MD, FRCPath
Journal: Blood
Blood (2010) 116 (21): 1841.
https://doi.org/10.1182/blood.V116.21.1841.1841
Published: 2010